PolyPid Agrees With ADVANZ PHARMA To Terminate Their 2022 Exclusive License, Distribution And Supply Agreement For D-PLEX₁₀₀ In Europe

Benzinga · 1d ago

As a result, the exclusive European commercialization rights for D-PLEX₁₀₀ have reverted to PolyPid.